About US Peptide Guide
A vendor-neutral, citation-dense reference for peptide therapies. Built for clinicians, researchers, and informed patients who need accurate evidence summaries — not marketing copy.
PubMed papers, FDA documents, or named expert sources with dates. No assertion ships without a reference or an explicit hedge ("no human data available").
Animal data, case reports, and human RCTs are always reported in distinct sections — never blended or averaged into a single "evidence" summary.
Every peptide page uses the same scale. Tier 1 (FDA-approved) through Tier 4 (animal data only). No exceptions. Lets you compare across peptides on a shared standard.
Dosing decisions belong with a licensed prescriber who can evaluate your individual context. We do not recommend vendors or products on reference pages.
Who this is for
- Clinicians evaluating peptide therapies for their patients
- Researchers looking for a clean evidence summary before diving into primary literature
- Patients who want to understand the actual strength of evidence before a clinical conversation
- Journalists and policymakers tracking FDA compounding reclassification events